Search clinical trials for: MV140

Total 6 results

Inmunotek S.L.

Completed

Evaluation of the Efficacy and Safety of MV140 (MV140)

Urinary Tract Infection Bacterial

Spain, United Kingdom
Impatients N.V. trading as myTomorrows
Inmunotek S.L.

No longer available

Expanded Access Program Using Uromune for Patients With Recurrent Urinary Tract Infections (rUTI)

Urinary Tract Infections | Bladder Infection | Recurrent Urinary Tract Infection | Urinary Tract Infection Bacterial | Chronic Urinary Tract Infection

Czechia, Denmark, Serbia, France, Germany, Turkey, Belgium, Finland, Luxembourg, Netherlands, Norway, Romania, Slovakia, Slovenia, Sweden
Inmunotek S.L.

Active, not recruiting

Evaluation of the Efficacy and Safety of MV130 in Chronic Obstructive Pulmonary Disease (COPD) (MV130)

Chronic Obstructive Pulmonary Disease (COPD)

Spain
Inmunotek S.L.

Not yet recruiting

Study to Evaluate the Ability of Sublingual MV130 to Induce the Expression of Trained Immunity in Peripheral Blood Cells

Immune Response
Inmunotek S.L.

Withdrawn

Efficacy of BACMUNE (MV130) in the Prevention of Disease Due to COVID-19 Infection in Healthcare Personnel (Bacmune)

Covid19

Mexico
EMD Serono Research & Development Institute, Inc.
Merck KGaA, Darmstadt, Germany

Recruiting

Anti-CEACAM5 ADC M9140 in Advanced Solid Tumors

Colorectal Cancer

United States, Japan, Spain

3

Subscribe